Table 2.
Case | CpG 1 | CpG 2 | CpG 3 | CpG 4 | CpG 6 | CpG 7 | CpG 8 | CpG 9 | CpG 10 | CpG 11 | CpG 12 | CpG 13 | CpG 14 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
37 | 84 | 84 | 78 | 67 | 77 | 85 | 82 | 83 | 74 | 82 | 79 | 89 | 80 |
50 | 83 | 84 | 74 | 71 | 73 | 81 | 80 | 83 | 74 | 76 | 75 | 85 | 83 |
80 | 86 | 92 | 85 | 56 | 82 | 88 | 79 | 81 | 83 | 84 | 73 | 84 | 88 |
91 | 83 | 88 | 81 | 70 | 74 | 90 | 87 | 84 | 74 | 81 | 73 | 88 | 80 |
95 | 9 | 8 | 11 | 10 | 10 | 8 | 7 | 8 | 7 | 11 | 10 | 10 | 12 |
102 | 70 | 73 | 68 | 64 | 66 | 74 | 71 | 75 | 67 | 74 | 70 | 78 | 76 |
Reference range | 86–96 | 87–97 | 84–93 | 61–88 | 82–88 | 83–100 | 85–97 | 85–97 | 74–92 | 83–92 | 73–95 | 89–99 | 84–96 |
Hypomethylated CpGs are indicated in bold. All patients showed hypomethylation affecting more than 50 % of the CpGs